Anja Geldhof

1.2k total citations
47 papers, 945 citations indexed

About

Anja Geldhof is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Rheumatology. According to data from OpenAlex, Anja Geldhof has authored 47 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 18 papers in Public Health, Environmental and Occupational Health and 7 papers in Rheumatology. Recurrent topics in Anja Geldhof's work include Immune Cell Function and Interaction (16 papers), Pregnancy and Medication Impact (15 papers) and T-cell and B-cell Immunology (14 papers). Anja Geldhof is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Pregnancy and Medication Impact (15 papers) and T-cell and B-cell Immunology (14 papers). Anja Geldhof collaborates with scholars based in Belgium, Netherlands and United States. Anja Geldhof's co-authors include Patrick De Baetselier, Geert Raes, Kris Thielemans, Jo A. Van Ginderachter, Muriel Moser, Richard Melsheimer, T Schaible, Laurence Lespagnard, Siamon Gordon and Gordon D. Brown and has published in prestigious journals such as Blood, The Journal of Immunology and Gastroenterology.

In The Last Decade

Anja Geldhof

44 papers receiving 919 citations

Peers

Countries citing papers authored by Anja Geldhof

Since Specialization

Citations

This map shows the geographic impact of Anja Geldhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Geldhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Geldhof more than expected).

Fields of papers citing papers by Anja Geldhof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Geldhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Geldhof. The network helps show where Anja Geldhof may publish in the future.

Co-authorship network of co-authors of Anja Geldhof

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Geldhof. A scholar is included among the top collaborators of Anja Geldhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Geldhof. Anja Geldhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term cardiovascular safety of ustekinumab in psoriasis and psoriatic arthritis: Results from an observational postauthorization safety study based on Swedish national registers 2025 ·Journal of the American Academy of Dermatology ·Jonas Banefelt, (unknown), (unknown), (unknown), Robert Suruki, Anja Geldhof	0
2	Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019 2024 ·Pharmacoepidemiology and Drug Safety ·Pär Karlsson, (unknown), (unknown), Anja Geldhof, Mika Gissler, Maarit K. Leinonen, (unknown), Lars Pedersen, Carolyn E. Cesta	1
3	Exposure to golimumab during pregnancy: Results from the Company's global safety database 2024 ·Pharmacology Research & Perspectives ·(unknown), (unknown), (unknown), Kathleen G. Lomax, Anja Geldhof, (unknown)	2
4	O09 Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study 2023 ·British Journal of Dermatology ·E. Mahé, Anja Geldhof, (unknown), Joerg Schreiber, (unknown), Michela Efficace, Marieke M.B. Seyger	1
5	Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database 2022 ·Alimentary Pharmacology & Therapeutics ·Uma Mahadevan, (unknown), Ilia Tikhonov, (unknown), (unknown), Anja Geldhof, C. Janneke van der Woude	19
6	Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)—a company experience 2022 ·Journal of Pharmaceutical Health Care and Sciences ·(unknown), Linda Quinn, (unknown), (unknown), W. Noël, Anja Geldhof, Nicole Herijgers, (unknown)	6
7	Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database 2020 ·Clinical Drug Investigation ·Najat J. Ziyadeh, Anja Geldhof, W. Noël, (unknown), (unknown), Soumya D. Chakravarty, Yi‐Ting Wang, John D. Seeger	4
8	Exposure to Infliximab During Pregnancy: Post-Marketing Experience 2019 ·Drug Safety ·Anja Geldhof, J. H. Slater, Michael B. Clark, Urmila Chandran, Danielle Coppola	19
9	Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition. 2006 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), Patrick Durez, René Westhovens, Filip Van den Bosch, Herman Mielants, Luc S. De Clerck, (unknown), Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Filip De Keyser	1
10	Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect 2006 ·Annals of the Rheumatic Diseases ·Bert Vander Cruyssen, Patrick Durez, René Westhovens, Filip Van den Bosch, Herman Mielants, Luc S. De Clerck, (unknown), Michel Malaise, Leon Verbruggen, (unknown), Anja Geldhof, Filip De Keyser	1
11	Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity 2006 ·Arthritis Research & Therapy ·Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, René Westhovens, Patrick Durez, Filip Van den Bosch, Herman Mielants, Luc S. De Clerck, (unknown), Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Luc Boullart, Filip De Keyser	46
12	Comparison of embryo quality in high-yielding dairy cows, in dairy heifers and in beef cows 2005 ·Theriogenology ·Jo Leroy, G. Opsomer, Sarne De Vliegher, Tom Vanholder, (unknown), Anja Geldhof, P.E.J. Bols, Aart de Kruif, Ann Van Soom	79
13	Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells 2003 ·The Journal of Immunology ·Yuanqing Liu, Jo A. Van Ginderachter, Lea Brys, Patrick De Baetselier, Geert Raes, Anja Geldhof	85
14	Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo 2003 ·European Journal of Immunology ·Philip R. Taylor, Gordon D. Brown, Anja Geldhof, Luisa Martı́nez-Pomares, Siamon Gordon	104
15	Ablation of NK Cell Function During Tumor Growth Favors Type 2‐Associated Macrophages, Leading to Suppressed CTL Generation 2003 ·Journal of Immunology Research ·Anja Geldhof, Jo A. Van Ginderachter, Yuanqing Liu, W. Noël, Patrick De Baetselier	5
16	Morphometric analysis of cytolysis in cultured cell monolayers: a simple and versatile method for the evaluation of the lytic activity and the fate of LAK cells 2002 ·Journal of Immunological Methods ·(unknown), Patrick De Baetselier, Hendrik Verschueren, Anja Geldhof	2
17	B7-1, IFNγ and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma 2000 ·International Journal of Cancer ·Jo A. Van Ginderachter, (unknown), Anja Geldhof, (unknown), (unknown), (unknown), Geert Raes	23
18	Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity 1998 ·International Journal of Cancer ·Laurence Lespagnard, Pascal Mettens, (unknown), (unknown), Kris Thielemans, Sonja Van Meirvenne, Anja Geldhof, Patrick De Baetselier, Jacques Urbain, Oberdan Léo, Muriel Moser	59
19	IL-12-Activated NK Cells Recognize B7 Costimulatory Molecules on Tumor Cells and Autologous Dendritic Cells 1998 ·Advances in experimental medicine and biology ·Anja Geldhof, Muriel Moser, Patrick De Baetselier	9
20	Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein 1993 ·Molecular Immunology ·Jean‐Pierre Y. Scheerlinck, Robert Deleys, Eric Saman, Lea Brys, Anja Geldhof, (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact